Alan P. Lyss - Concepedia

Author

Alan P. Lyss

Missouri Baptist Medical Center

Also Known As

A Lyss, A P Lyss, A. Lyss, A. P. Lyss, A.P Lyss, A.P. Lyss, Alan Lyss, Alan P Lyss, Alan P. Lyss, Rafat H. Ansari

Publications

4.4K

Citations

H-Index

Concepts

All Affiliations

Missouri Baptist Medical Center Heartland Cancer Research Memorial Sloan Kettering Cancer Center The University of Texas MD Anderson Cancer Center Dana-Farber Cancer Institute

About

Alan P. Lyss is an author at Missouri Baptist Medical Center specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	28	1.8K
2	Health Sciences	6	6	581
3	Nursing	3	3	85
4	Social Sciences	1	1	25
5	Allergy	1	1	250

Alan P. Lyss

Publications

3.9K

Citations

H-Index

Page 1

	Year	Citations
Phase III Study of Immediate Compared With Delayed Docetaxel After Front-Line Therapy With Gemcitabine Plus Carboplatin in Advanced Non–Small-Cell Lung Cancer Panos Fidias, Shaker R. Dakhil, Alan P. Lyss, Journal of Clinical Oncology	2008	421
Anthracyclines in Early Breast Cancer: The ABC Trials—USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 (NRG Oncology) Joanne L. Blum, Patrick J. Flynn, Greg Yothers, Journal of Clinical Oncology	2017	280
Presence of complement-fixing anti-endothelial cell antibodies in systemic lupus erythematosus. Douglas B. Cines, Alan P. Lyss, Miriam J. Reeber, Journal of Clinical Investigation VasculitisEndothelial CellsImmunologyPathologyImmunotherapy	1984	250
Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): interim analysis of a multicentre, open-label, randomised, phase 3 study Erica L. Mayer, Amylou C. Dueck, Miguel Martín, The Lancet Oncology Interim AnalysisEndocrine OncologyBreast OncologyOncologyEarly Breast Cancer	2021	250
Oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in cancer patients: a controlled dose titration study Russell K. Portenoy, Richard Payne, Paul Coluzzi, Pain	1999	240
Positron tomographic assessment of 16 alpha-[18F] fluoro-17 beta-estradiol uptake in metastatic breast carcinoma. Andrea H. McGuire, Farrokh Dehdashti, Barry A. Siegel, PubMed Breast OncologyOncologic ImagingPet-mriPathologyTumor Uptake	1991	238
Randomized Phase III Trial of Paclitaxel Once Per Week Compared With Nanoparticle Albumin-Bound Nab-Paclitaxel Once Per Week or Ixabepilone With Bevacizumab As First-Line Chemotherapy for Locally Recurrent or Metastatic Breast Cancer: CALGB 40502/NCCTG N063H (Alliance) Hope S. Rugo, William T. Barry, Alvaro Moreno‐Aspitia, Journal of Clinical Oncology	2015	226
70 Gy thoracic radiotherapy is feasible concurrent with chemotherapy for limited-stage small-cell lung cancer: analysis of Cancer and Leukemia Group B study 39808 Jeffrey A. Bogart, James E. Herndon, Alan P. Lyss, International Journal of Radiation OncologyBiologyPhysics Radiation MedicineRadiation TherapyMedicineFeasible ConcurrentBronchial Neoplasm	2004	178
Fc and C3 Receptors Induced by Herpes Simplex Virus on Cultured Human Endothelial Cells Douglas B. Cines, Alan P. Lyss, Mahin Bina, Journal of Clinical Investigation Viral PathogenesisImmunologyInflammationC3 Receptors InducedViral Persistence	1982	150
The National Cancer Institute–American Society of Clinical Oncology Cancer Trial Accrual Symposium: Summary and Recommendations Andrea Denicoff, Worta McCaskill‐Stevens, Stephen S. Grubbs, Journal of Oncology Practice	2013	142

Page 1